FDA Inspection 596383 — Propak Development, Inc.

Propak Development, Inc. — FEI 3004420929

The FDA completed an inspection of Propak Development, Inc. on Jun 17, 2009 in Dayton, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 17, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dayton, NJ (United States)

Citations

IDCFRDescription
357021 CFR 211.100(a)Approval and review of procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.